Compassionate use of a paclitaxel coated balloon in patients with refractory recurrent coronary in-stent restenosis

Abstract

DCB appear to be safe and clinically useful in the treatment of ISR. DCB is a new promising option for high-risk patients with refractory ISR.

Recurrent restenosis in drug-eluting stents: Still looking for the best treatment?

“…p l / k a r d i o l o g i a _ p o l s k a showed marked superiority. a year later, in 2014, Clever et al [12] tested using DEB in treatment of r-ISr even before it was available in Europe. They tested it in 28 lesions in patients for whom surgery was not an option, so they called the test a compassionate use of DEB (exploratory use, in our opinion), and DEB showed a good safety and efficacy profile as only 2 of 28 lesions required revascularization later on.…”